Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy

Antibodies against PD1 have been used to treat progressive multifocal leukoencephalopathy (PML), a rare brain disease caused by JC virus. We used these antibodies (nivolumab) to treat PML in 3 kidney transplant recipients. All died within 8 weeks of diagnosis. Hence, nivolumab did not improve PML ou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Emerg Infect Dis
Egile Nagusiak: Medrano, Chloé, Vergez, François, Mengelle, Catherine, Faguer, Stanislas, Kamar, Nassim, Del Bello, Arnaud
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Centers for Disease Control and Prevention 2019
Gaiak:
Research Letter
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810212/
https://ncbi.nlm.nih.gov/pubmed/31625858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2511.190705
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak